Gérald Ulrich
Vorstandsvorsitzender bei Aterovax SA
Profil
Gérald Ulrich is the founder of Novacyt SAS, which was founded in 2006.
He held the title of Commercial Director from 2006 to 2012.
Dr. Ulrich is currently the Chairman & Chief Executive Officer at Aterovax SA. In the past, he worked as a Senior Marketing Officer at Theradiag SA and as a Biologist Practitioner at Laboratoire Cerba SA.
Aktive Positionen von Gérald Ulrich
| Unternehmen | Position | Beginn |
|---|---|---|
Aterovax SA
 Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | Vorstandsvorsitzender | 23.07.2011 |
Ehemalige bekannte Positionen von Gérald Ulrich
| Unternehmen | Position | Ende |
|---|---|---|
| NOVACYT | Gründer | 01.04.2012 |
| THERADIAG | Corporate Officer/Principal | - |
Laboratoire Cerba SA
 Laboratoire Cerba SA Miscellaneous Commercial ServicesCommercial Services Laboratoire Cerba SA provides medical research services. It conducts tests in the fields of virology, autoimmune disease, allergy, endocrinology, oncology, toxicology and molecular genomics. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVACYT | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France. | Health Services |
Laboratoire Cerba SA
Laboratoire Cerba SA Miscellaneous Commercial ServicesCommercial Services Laboratoire Cerba SA provides medical research services. It conducts tests in the fields of virology, autoimmune disease, allergy, endocrinology, oncology, toxicology and molecular genomics. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. | Commercial Services |
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
